DCT
1:22-cv-01040
Novo Nordisk Inc v. Mylan Pharma Inc
General
Cause of ActionPatent Infringement
SectorMech Eng, Manuf
Status
Closed (09/11/24)
Patent Owner
Operating Company (L)
SourcePACER
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
08/22/22 - 10/02/24 | 41% | |
03/25/22 - 08/22/22 | 58% | |
03/25/22 - 03/25/22 | 50% |
Plaintiff
Party
Attorney
Defendant
Party
Attorney